Robarts Clinical Trials Revenue and Competitors

London, ON CAN

Location

N/A

Total Funding

Pharma

Industry

Estimated Revenue & Valuation

  • Robarts Clinical Trials's estimated annual revenue is currently $152.6M per year.(i)
  • Robarts Clinical Trials's estimated revenue per employee is $201,000

Employee Data

  • Robarts Clinical Trials has 759 Employees.(i)
  • Robarts Clinical Trials grew their employee count by 14% last year.

Robarts Clinical Trials's People

NameTitleEmail/Phone
1
Director, Quality AssuranceReveal Email/Phone
2
Director FinanceReveal Email/Phone
3
Director, Medical OperationsReveal Email/Phone
4
Director, Business Development Europe and Asia PacificReveal Email/Phone
5
Data ManagerReveal Email/Phone
6
Desktop Support SpecialistReveal Email/Phone
7
Team Lead, TMF OperationsReveal Email/Phone
8
Sr. Clinical Operations Lead (Sr. Lead CRA)Reveal Email/Phone
9
Senior Quality Assurance SpecialistReveal Email/Phone
10
Lead CRA Reveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$11.7M58-37%N/AN/A
#2
$17.3M866%N/AN/A
#3
$43.8M21822%N/AN/A
#4
$7.6M38-3%N/AN/A
#5
$17.9M983%$192.2MN/A
#6
$59.1M294-9%N/AN/A
#7
$0.5M5-58%N/AN/A
#8
$8.2M41-41%N/AN/A
#9
$25.9M12929%N/AN/A
#10
$6.7M6763%N/AN/A
Add Company

What Is Robarts Clinical Trials?

Robarts Clinical Trials is an internationally recognized full-service Contract Research Organization. Since 1986 we have collaborated with pharmaceutical and biotechnology industries, government agencies, and academic investigators in the performance of global, multi-centre, randomized controlled trials. We integrate content area expertise with practical hands-on experience in managing the many aspects of a trial. Our proven expertise enables you to achieve maximum efficiency for your research.

keywords:N/A

N/A

Total Funding

759

Number of Employees

$152.6M

Revenue (est)

14%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Robarts Clinical Trials News

2022-04-06 - Difficult-to-treat inflammatory bowel disease: results from a ...

VJ has received consulting and advisory board fees from AbbVie, Alimentiv (formerly Robarts Clinical Trials), Arena Pharmaceuticals, Asahi Kasei Pharma,...

2022-03-30 - Morphic Therapeutic Announces Initiation of EMERALD-1 ...

Phase 2b EMERALD-2 clinical trial of MORF-057 expected to begin mid-year 2022 ... The primary endpoint of the trial is the change in Robarts...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$345.8M760-1%N/A
#2
$241.5M76023%N/A
#3
$154.3M760-6%$2B
#4
$149.2M76158%N/A
#5
$246.7M763-6%N/A